Data from: Implementation of a pediatric telemedicine and medication delivery service in a resource-limited setting: A pilot study for clinical safety and feasibility

Objective: Determine the clinical safety and feasibility of implementing a telemedicine and medication delivery service (TMDS) to address gaps in nighttime healthcare access for children in low-resource settings. Results: A total of 391 cases were enrolled from September 9th, 2019 to January 19th, 2021; 89% (347) received a household visit. Most cases were triaged as mild or moderate (92%; 361). Among the severe cases, 83% (20) sought subsequent referred care. The most common complaint was a respiratory problem (63%; 246). At 10-days, 95% (329) of parents reported their child's condition as "improved" or "recovered". Ninety-nine percent (344) rated the TMDS as "good" or "great". The median phone consultation was 20 minutes, time to arrival at the household was 73 minutes and total workflow per case was 114 minutes. Conclusion: The TMDS was a feasible healthcare delivery model with high rates of improved clinical status at 10-days.Each row of the INACT2_Data_5.9.22 file corresponds to a case. The list of variables and corresponding codes are provided in the README_INACT2_Data.txt file.Funding provided by: National Institutes of HealthCrossref Funder Registry ID: http://dx.doi.org/10.13039/100000002Award Number: DP5OD019893We conducted 391 virtual exams on children ≤10 yrs with the MotoMeds telemedicine and medication delivery service in Gressier Haiti and 341 of these cases received a paired in-person exam at their home following the virtual exam. Data pertaining to the call center and houshold exams as well as operational metrics and user feedback data were collected by Haitian nurses at the MotoMeds call center and during household visits in the surrounding study area. The data were originally recorded on paper case report (CRF) forms and then entered into REDCap by a Haitian study coordinator. Two independent physicians conducted chart reviews to evaluate guideline adherence. They entered the case review data directly into REDCap. Seventy-four nasal swabs were collected from participants with respiratory complaints or fever and analyzed using BioFire COVID-19 Test v1.0 or BioFire Respiratory Panel 2.1. The laboratory results were entered into REDCap by the Haitian study coordinator. The raw data set was reduced to the most relevant variables to answer our research questions and dates, times, names, GPS coordinates, and phone numbers were removed and case IDs were scrambled